About Concur Lives
Concur Lives is a company. It operates as a B2B. The company has 61 employees as of March 31, 2023. Concur Lives offers products and services including Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications. Concur Lives operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Employees 61 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Concur Pharmaceuticals Private Limited
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$1.02 M (USD)9.34as on Mar 31, 2023
-
Net Profit
$31.84 K (USD)13.2as on Mar 31, 2023
-
EBITDA
$141.32 K (USD)11.63as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
61
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Concur Lives
Concur Lives offers a comprehensive portfolio of products and services, including Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications.
Medications for managing neurological disorders effectively.
Treatments for cardiovascular conditions and related health issues.
Products for orthopedic disorders and bone health management.
Drugs addressing gynaecological health and related concerns.
Funding Insights of Concur Lives
Detailed funding history for Concur Lives
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concur Lives
Investment portfolio details for Concur Lives
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Concur Lives
Detailed financials for Concur Lives
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concur Lives Comparisons
Peer comparison for Concur Lives
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concur Lives
Concur Lives operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Concur Lives
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concur Lives
Complete news archive for Concur Lives
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concur Lives
As of Mar 31, 2023, the latest employee count at Concur Lives is 61.
Annual revenue of Concur Lives is $1.02M as on Mar 31, 2023.
Concur Pharma, established in 2011 in New Delhi, India, specializes in developing and marketing pharmaceutical products for chronic diseases such as Nephrology, Neurological Disorders, Gynaecology, and Orthopedics. It operates through customer-dedicated marketing teams and comprehensive portfolios, serving healthcare needs in India and 12 other countries. The company focuses on innovative, out-of-the-box solutions to address unmet medical gaps and promote better disease management.
Concur Lives's top competitors include Merck, Roivant Sciences and AbbVie.
Concur Lives offers Neurological Drugs, Cardiovascular Products, Orthopedic Solutions, and Gynaecology Medications.